SRC Antibodies

Santa Cruz Biotechnology features a diverse variety of SRC Antibodies for advanced research in cellular signaling and cancer biology. SRC Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SRC is a non-receptor tyrosine kinase that plays a critical role in regulating cell growth, differentiation, and survival. SRC actively participates in multiple signaling pathways and significantly influences the progression of various cancers, making it a key target for therapeutic intervention. Understanding SRC function and interactions provides crucial insights into the mechanisms of tumorigenesis and aids in developing targeted cancer therapies. Researchers worldwide rely on SRC monoclonal antibodies to investigate cellular pathways and molecular mechanisms in cancer development. Advanced detection methods, including fluorescent conjugates like phycoerythrin (PE), fluorescein isothiocyanate (FITC), and horseradish peroxidase (HRP), enable precise visualization of SRC in experimental settings. Santa Cruz Biotechnology monoclonal antibodies for SRC continue to advance scientific understanding of cancer biology and contribute to the development of innovative therapeutic strategies.